FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000598830> ?p ?o ?g. }

• W2000598830 endingPage "1084" @default.
• W2000598830 startingPage "1083" @default.
• W2000598830 abstract "Trottier et al.,1 in a masterful paper, show that human hepatic microsomes convert chenodeoxycholic acid predominantly to a C-24 ester glucuronide and that such glucuronidation is mediated mainly by the enzyme UGT1A3. Nonetheless, multiple studies have shown that in health as well as in liver disease, bile acid glucuronidation is a very minor pathway, based on measurements of urinary2, 3 and biliary bile acid glucuronides.2 The purpose of this note is to explain this apparent contradiction. In bile acid biosynthesis from cholesterol, the carboxyl group at C-24 remains in Coenzyme A linkage until the carboxyl group undergoes N-acyl amidation with glycine or taurine. Because the resulting bile acid amidates are relatively strong acids and fully ionized at intracellular pH, they cannot partition into the smooth endoplasmic reticulum and are not esterified with glucuronic acid, as shown by Trottier et al.1 The major flux of bile acids through hepatocytes consists of bile acids returning from the intestine. The majority of these is in conjugated form and thus cannot undergo glucuronidation. Some bile acids are also present in unconjugated form, formed by bacterial deconjugation in the distal intestine. Such unconjugated bile acids are transported across the sinusoidal membrane of the hepatocyte by FATP5 which immediately esterifies them with Coenzyme A.4 The Coenzyme A thio-ester rapidly transfers the bile acid to the amino group of glycine or taurine either in the cytosol and/or peroxisomes, again precluding glucuronidation. There are, however, at least four experimental situations, three in animals and two in humans, in which extensive glucuronidation of bile acids occurs. In the biliary fistula rat, when bile acids are infused at a rate exceeding the amidation capacity of the hepatocyte, glucuronidation occurs.5 In the perfused rat liver, when the hepatocyte is acidified by amiloride, glucuronidation of ursodeoxycholic acid (UDCA) increases markedly.6 Hyodeoxycholic acid (HDCA) (possessing α-hydroxy groups at C-3 and C-6) is a dihydroxy, secondary bile acid that occurs in pigs and rodents. When HDCA is given to healthy subjects. efficient ethereal hydroxylation at C-6 occurs and is mediated by UGT2B4 and UGT2B7,7, 8 presumably because this non-endogenous bile acid is a poor substrate for one or both of the steps involved in N-acyl amidation. The final instance of extensive bile acid glucuronidation occurs in both animals9 and humans10 when C23 (C-24 nor) dihydroxy bile acids are administered. Nor dihydroxy bile acids are poor substrates for the Coenzyme A ligase. The unconjugated bile acid partitions into the smooth endoplasmic reticulum and undergoes glucuronidation at C-3 or C-23 (animals) or only C-23 (humans), in agreement with the observations of Trottier et al.1 In humans, the C-6 glucuronide of hyodeoxycholic acid as well as the C-23 glucuronide of norUDCA are excreted in both urine and bile.7, 10 In summary, hepatic N-acyl amidation with glycine or taurine of newly synthesized bile acids as well as unconjugated bile acids returning from the intestine is highly efficient in health and in liver disease. As a result, ester glucuronidation at C-24, the major bile acid glucuronidation pathway in man, cannot occur because the two pathways are mutually exclusive. Thus, glucuronidation, the major phase II biotransformation pathway for many drugs, remains a very minor pathway for conjugation of endogenous bile acids in man. Alan F. Hofmann M.D.*, * Department of Medicine, University of California, San Diego, La Jolla, CA." @default.
• W2000598830 created "2016-06-24" @default.
• W2000598830 creator A5044521722 @default.
• W2000598830 date "2007-01-01" @default.
• W2000598830 modified "2023-09-27" @default.
• W2000598830 title "Why bile acid glucuronidation is a minor pathway for conjugation of endogenous bile acids in man" @default.
• W2000598830 cites W1516552920 @default.
• W2000598830 cites W1862854649 @default.
• W2000598830 cites W1965444999 @default.
• W2000598830 cites W1968536438 @default.
• W2000598830 cites W1983465516 @default.
• W2000598830 cites W1985641799 @default.
• W2000598830 cites W2009437300 @default.
• W2000598830 cites W2070551450 @default.
• W2000598830 cites W2087631934 @default.
• W2000598830 doi "https://doi.org/10.1002/hep.21576" @default.
• W2000598830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17393523" @default.
• W2000598830 hasPublicationYear "2007" @default.
• W2000598830 type Work @default.
• W2000598830 sameAs 2000598830 @default.
• W2000598830 citedByCount "16" @default.
• W2000598830 countsByYear W20005988302013 @default.
• W2000598830 countsByYear W20005988302014 @default.
• W2000598830 countsByYear W20005988302015 @default.
• W2000598830 countsByYear W20005988302016 @default.
• W2000598830 countsByYear W20005988302018 @default.
• W2000598830 countsByYear W20005988302019 @default.
• W2000598830 countsByYear W20005988302020 @default.
• W2000598830 countsByYear W20005988302021 @default.
• W2000598830 crossrefType "journal-article" @default.
• W2000598830 hasAuthorship W2000598830A5044521722 @default.
• W2000598830 hasBestOaLocation W20005988301 @default.
• W2000598830 hasConcept C10213722 @default.
• W2000598830 hasConcept C181199279 @default.
• W2000598830 hasConcept C185592680 @default.
• W2000598830 hasConcept C2777756961 @default.
• W2000598830 hasConcept C2779399885 @default.
• W2000598830 hasConcept C2779701627 @default.
• W2000598830 hasConcept C2779907587 @default.
• W2000598830 hasConcept C2780965833 @default.
• W2000598830 hasConcept C39321552 @default.
• W2000598830 hasConcept C515207424 @default.
• W2000598830 hasConcept C55493867 @default.
• W2000598830 hasConcept C62231903 @default.
• W2000598830 hasConcept C87644729 @default.
• W2000598830 hasConceptScore W2000598830C10213722 @default.
• W2000598830 hasConceptScore W2000598830C181199279 @default.
• W2000598830 hasConceptScore W2000598830C185592680 @default.
• W2000598830 hasConceptScore W2000598830C2777756961 @default.
• W2000598830 hasConceptScore W2000598830C2779399885 @default.
• W2000598830 hasConceptScore W2000598830C2779701627 @default.
• W2000598830 hasConceptScore W2000598830C2779907587 @default.
• W2000598830 hasConceptScore W2000598830C2780965833 @default.
• W2000598830 hasConceptScore W2000598830C39321552 @default.
• W2000598830 hasConceptScore W2000598830C515207424 @default.
• W2000598830 hasConceptScore W2000598830C55493867 @default.
• W2000598830 hasConceptScore W2000598830C62231903 @default.
• W2000598830 hasConceptScore W2000598830C87644729 @default.
• W2000598830 hasIssue "4" @default.
• W2000598830 hasLocation W20005988301 @default.
• W2000598830 hasLocation W20005988302 @default.
• W2000598830 hasOpenAccess W2000598830 @default.
• W2000598830 hasPrimaryLocation W20005988301 @default.
• W2000598830 hasRelatedWork W1587157176 @default.
• W2000598830 hasRelatedWork W1590993351 @default.
• W2000598830 hasRelatedWork W1964504097 @default.
• W2000598830 hasRelatedWork W2000598830 @default.
• W2000598830 hasRelatedWork W2247894225 @default.
• W2000598830 hasRelatedWork W2333164327 @default.
• W2000598830 hasRelatedWork W2605028567 @default.
• W2000598830 hasRelatedWork W2766961351 @default.
• W2000598830 hasRelatedWork W2921153261 @default.
• W2000598830 hasRelatedWork W2005404302 @default.
• W2000598830 hasVolume "45" @default.
• W2000598830 isParatext "false" @default.
• W2000598830 isRetracted "false" @default.
• W2000598830 magId "2000598830" @default.
• W2000598830 workType "article" @default.